“We are pleased to serve thousands of home healthcare companies, medical supply distributors, pharmacies, hospitals, and physicians. Our customers share our commitment to providing the highest quality ...
PARI Respiratory Equipment, a worldwide developer and manufacturer of aerosol delivery systems, won a 2015 American Package Design Award for Kitabis Pak®. Kitabis Pak, approved by the FDA last ...
We wish there were more brands that offered plus sizes, but the truth is that designing for larger bodies is not as simple as adding more fabric. Perhaps no one knows this better than Shanna Goldstone ...
A randomized, open-label, crossover study was performed. In 2 separate study visits, blood samples from 22 children were collected following TIS nebulization with I-neb (75 mg) and PARI-LC Plus (300 ...
MIDLOTHIAN, Va., Nov. 29, 2018 /PRNewswire/ -- A recent study in preschoolers with cystic fibrosis (CF) conducted by Cystic Fibrosis Foundation Therapeutics used PARI's LC Sprint Jr. nebulizer, Vios ...
STARNBERG, Germany, June 7, 2016 /PRNewswire/ -- PARI Pharma, a company focused on the development of advanced aerosol therapies using eFlow Technology, announces that its proprietary closed eFlow ...
PARI Respiratory Equipment, Inc. has been awarded a 2015 WebAward for Outstanding Achievement in Web Development by the Web Marketing Association (WMA). This content was written and submitted by the ...
Kitabis Pak (tobramycin inhalation solution) is now on the Preferred Drug List (PDL) for many state programs, expanding its access for patients with cystic fibrosis (CF) using nebulized antibiotic ...
From FDA’s Sickle Cell Disease awareness efforts to an award-winning inhalation pack to Xavier’s new graduate program, there is a lot going on when it comes to clinical trials. Healthcare Packaging ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback